Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №3 (2024) > Role of blood glucose self-monitoring in management of gestational diabetes mellitus

Role of blood glucose self-monitoring in management of gestational diabetes mellitus

Galina A. Batrak , Nataliya V. Batrak

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Gestational diabetes mellitus (GDM) is a disorder characterized by hyperglycemia first recognized during pregnancy that does not meet the criteria of manifest diabetes mellitus (DM). The GDM decompensation can be a common cause of perinatal mortality. GDM is associated with higher rates of preeclampsia and eclampsia, which require emergency caesarean section [1].  Contemporary approach to GDM management includes the need for mandatory self-monitoring of blood glucose. The target blood glucose range cannot be achieved without self-monitoring of blood glucose done by the pregnant woman at home. Glycemic control during pregnancy should be accurate, simple and user-friendly, allowing the pregnant woman to adjust insulin therapy for GDM by herself. Choosing a blood glucose meter is one of the major aspects of blood glucose self-monitoring. From the physician's perspective, compliance with accuracy standards is the most important criterion for blood glucose meter selection, while from the patient’s perspective, the most important criteria are user friendliness, and simplicity of use. Blood glucose level measurement accuracy is improved, and self-monitoring of blood glucose becomes easier due to technical improvements, which results in improved adherence to treatment and higher therapy efficacy. Achieving and maintaining glycemic targets are impossible without active and meaningful participation of the patient with GDM, as well as without self-monitoring of blood glucose with precise and user-friendly blood glucose meter, such as Contour Plus One. 
Keywords: self-monitoring of blood glucose, Contour Plus One blood glucose meter, gestational diabetes mellitus.

About the Author

Galina A. Batrak 1 , Nataliya V. Batrak 1

1 Ivanovo State Medical University, Ivanovo, Russia

References

1. Эндокринология. Национальное руководство. Краткое издание. Под ред. И.И. Дедова, Г.А. Мельниченко. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2018. Endocrinology. National leadership. A short edition. Ed. I.I. Dedov, G.A. Melnichenko. 2nd ed., reprint and add. Moscow: GEOTAR-Media, 2018 (in Russian).
2. Батрак Г.А., Бродовская А.Н., Мясоедова С.Е. Роль самоконтроля гликемии в снижении риска развития диабетических микро- и макроангиопатий. Consilium Medicum. 2019;21(12):55-8.  Batrak G.A., Brodovskaya A.N., Myasoedova S.E. The role of self-control of glycemia in reducing the risk of developing diabetic micro- and macroangiopathies. Consilium Medicum. 2019;21(12):55-8 (in Russian).
3. Бродовская А.Н., Батрак Г.А. Взаимосвязь вариабельности гликемии и поражения почек у больных с впервые выявленным сахарным диабетом 2-го типа. Вестник Ивановской медицинской академии. 2018;23(2):48-9.  Brodovskaya A.N., Batrak G.A. The relationship between the variability of glycemia and kidney damage in patients with newly diagnosed type 2 diabetes mellitus. Bulletin of the Ivanovo Medical Academy. 2018;23(2):48-9 (in Russian).
4. Federation ID. IDF Diabetes Atlas. 9th edition Brussels, Belgium: International Diabetes Federation; 2019.
5. Metzger BE et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
6. Fetita L-S et al. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006;91(10): 3718-24.
7. Lowe WL et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):372-80.
8. Осложнения сахарного диабета: лечение и профилактика. Под. ред. И.И. Дедова, М.В. Шестаковой. М.: Медицинское информационное агентство, 2017.  Complications of diabetes mellitus: treatment and prevention. Edited by I.I. Dedov, M.V. Shestakova. Moscow: Medical Information Agency, 2017 (in Russian).
9. Сахарный диабет и репродуктивная система. Под. ред. И.И. Дедова, М.В. Шестаковой. М.: Медицинское информационное агентство, 2016.  Diabetes mellitus and the reproductive system. Edited by I.I. Dedov,  M.V. Shestakova. Moscow: Medical Information Agency, 2016 (in Russian).
10. Дедов И.И., Краснопольский В.И., Сухих Г.Т. Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение. Российский национальный консенсус. Сахарный диабет. 2012;15 (4):4-10.  Dedov I.I., Krasnopolsky V.I., Sukhoi G.T. Gestational diabetes mellitus: diagnosis, treatment, postpartum follow-up. The Russian national consensus. Diabetes mellitus. 2012;15 (4):4-10 (in Russian).
11. Metzger B, Oats J, Coustan D. Hod Results of the HAPO study: progress towards a new paradigm for detection & diagnosis of GDM. 5th International simposium on Diabetes and pregnancу. Italy (Sorrento), 2009.
12. Organization WH. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
13. Diabetes, I.A.o. and P.S.G.C. Panel, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010;33(3):676-82.
14. Organization WH. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization, 2013.
15. Hanna FW et al. Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c). Clinical Medicine. 2017;17(2):108.
16. Kintiraki E, Goulis DG. Gestational diabetes mellitus: Multi-disciplinary treatment approaches. Metabolism. 2018;86:91-101.
17. Скворцова М.В. Приказ Министерства здравоохранения Российской Федерации № 72н от 1 ноября 2012 г. Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология» (за исключением использования вспомогательных репродуктивных технологий). Российская газета, 2013.  Skvortsova M.V. Order of the Ministry of Health of the Russian Federation No. 72n dated November 1, 2012. On approval of the Procedure for providing medical care in the field of obstetrics and gynecology (with the exception of the use of assisted reproductive technologies). Rossiyskaya Gazeta, 2013 (in Russian).
18. Mendez-Figueroa H et al. Comparing daily versus less frequent blood glucose monitoring in patients with mild gestational diabetes. J Maternal-Fetal Neonatal Med. 2013;26(13):1268-72.
19. Hawkins JS et al. Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstetrics Gynecol. 2009;113(6):1307-12.
20. de Veciana M et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New Eng J Med. 1995;333(19):1237-41.
21. Mendez-Figueroa H et al. Gestational diabetes mellitus and frequency of blood glucose monitoring: a randomized controlled trial. Obstetrics Gynecol. 2017;130(1):163-70.
22. Laird M, Jason and McFarland M, FACE, Kay F. Fasting blood glucose levels and initiation of insulin therapy in gestational diabetes. Endocrine Practice. 1996;2(5):330-2.
23. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й выпуск. М., 2023.  Algorithms of specialized medical care for patients with diabetes mellitus. Ed. by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 11th edition. Moscow, 2023 (in Russian).
24. Moses GR, Luca EM, Knights S. Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored? Australian and New Zealand Journal of Obstetrics and Gynaecology. 1999;39(4):457-60.
25. Sivan E et al. One or two hours postprandial glucose measurements: are they the same? Am J Obstetrics Gynecol. 2001;185(3): 604-7.
26. Weisz B et al. One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J Perinat. 2005;25(4):241-2.
27. ГОСТ Р ИСО 15197–2015. Тест-системы для диагностики in vitro. Требования к системам мониторинга глюкозы в крови для самоконтроля при лечении сахарного диабета. М., 2015. URL: http://docs.cntd.ru/document/1200120137 GOST R ISO 15197–2015. In vitro diagnostic test systems. Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Moscow, 2015. URL: http://docs.cntd.ru/document/1200120137 (in Russian).
28. Гестационный сахарный диабет: диагностика, лечение, акушерская тактика, послеродовое наблюдение. Клинические рекомендации. М., 2020.  Gestational diabetes mellitus: diagnosis, treatment, obstetric tactics, postpartum follow-up. Clinical recommendations. Moscow, 2020 (in Russian).

For citation:G.A. Batrak, Batrak N.V. Role of blood glucose self-monitoring in management of gestational diabetes mellitus. Clinical review for general practice. 2024; 5 (3): 105–110. (In Russ.). DOI: 10.47407/kr2023.5.3.00379


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru